Cargando…

Clinical Characteristics of Autoimmune Hepatitis in a Middle Eastern Population: A Tertiary Care Center Experience

Autoimmune hepatitis (AIH) is an immune-mediated inflammatory liver disease of uncertain cause, and its manifestations appear to vary by race and ethnicity. The literature on AIH in the Middle East, including Jordan, is scarce; therefore, this study aimed to determine the clinical characteristics of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamimi, Tarek A., Sallam, Malik, Rayyan, Deema, Farah, Randa, Alkhulaifat, Dana, Al-Ani, Abdallah, Elmusa, Reem, Sharawi, Said, Tanash, Omar, Rayyan, Yaser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861091/
https://www.ncbi.nlm.nih.gov/pubmed/36675558
http://dx.doi.org/10.3390/jcm12020629
_version_ 1784874754805596160
author Tamimi, Tarek A.
Sallam, Malik
Rayyan, Deema
Farah, Randa
Alkhulaifat, Dana
Al-Ani, Abdallah
Elmusa, Reem
Sharawi, Said
Tanash, Omar
Rayyan, Yaser
author_facet Tamimi, Tarek A.
Sallam, Malik
Rayyan, Deema
Farah, Randa
Alkhulaifat, Dana
Al-Ani, Abdallah
Elmusa, Reem
Sharawi, Said
Tanash, Omar
Rayyan, Yaser
author_sort Tamimi, Tarek A.
collection PubMed
description Autoimmune hepatitis (AIH) is an immune-mediated inflammatory liver disease of uncertain cause, and its manifestations appear to vary by race and ethnicity. The literature on AIH in the Middle East, including Jordan, is scarce; therefore, this study aimed to determine the clinical characteristics of AIH in an understudied population. This retrospective chart review study was conducted on AIH patients who presented to Jordan University Hospital over a seven-year period (2014–2020). Retrieved data included sociodemographics, liver function tests, autoimmune serologic markers, viral hepatitis serology, findings on liver biopsies, treatment regimens, post-therapy outcomes and treatment-related complications. The total number of AIH patients included in the study was 30, divided as follows: type 1 AIH (n = 17, 56.7%), type 2 AIH (n = 2, 6.7%), seronegative AIH (n = 9, 30.0%), and two patients who had AIH-primary biliary cirrhosis overlap syndrome (6.7%). The mean age at diagnosis was 44 years (standard deviation: 17 years), with a female predominance (n = 25, 83.3%). Acute presentation was seen among 18 patients (60.0%). Mild to moderate fibrosis (F1 and F2 on METAVIR scoring system) without cirrhosis was observed among patients who underwent liver biopsies (10/19, 52.6%). The majority of patients (73.3%) were initially treated with prednisone, with azathioprine combination in 16.7% of the patients. At 6 months post initial treatment, twenty patients (66.7%) achieved biochemical remission, four patients had incomplete response, two patients failed to improve (one died during the induction of remission period due to AIH-related complications), and four patients were lost to follow-up. This study provided an updated overview of AIH in Jordan. The results showed typical female predominance, and interestingly high rates of acute presentation and seronegative disease. Future longitudinal studies are recommended to address the nature and long-term prognosis of AIH in Jordan.
format Online
Article
Text
id pubmed-9861091
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98610912023-01-22 Clinical Characteristics of Autoimmune Hepatitis in a Middle Eastern Population: A Tertiary Care Center Experience Tamimi, Tarek A. Sallam, Malik Rayyan, Deema Farah, Randa Alkhulaifat, Dana Al-Ani, Abdallah Elmusa, Reem Sharawi, Said Tanash, Omar Rayyan, Yaser J Clin Med Article Autoimmune hepatitis (AIH) is an immune-mediated inflammatory liver disease of uncertain cause, and its manifestations appear to vary by race and ethnicity. The literature on AIH in the Middle East, including Jordan, is scarce; therefore, this study aimed to determine the clinical characteristics of AIH in an understudied population. This retrospective chart review study was conducted on AIH patients who presented to Jordan University Hospital over a seven-year period (2014–2020). Retrieved data included sociodemographics, liver function tests, autoimmune serologic markers, viral hepatitis serology, findings on liver biopsies, treatment regimens, post-therapy outcomes and treatment-related complications. The total number of AIH patients included in the study was 30, divided as follows: type 1 AIH (n = 17, 56.7%), type 2 AIH (n = 2, 6.7%), seronegative AIH (n = 9, 30.0%), and two patients who had AIH-primary biliary cirrhosis overlap syndrome (6.7%). The mean age at diagnosis was 44 years (standard deviation: 17 years), with a female predominance (n = 25, 83.3%). Acute presentation was seen among 18 patients (60.0%). Mild to moderate fibrosis (F1 and F2 on METAVIR scoring system) without cirrhosis was observed among patients who underwent liver biopsies (10/19, 52.6%). The majority of patients (73.3%) were initially treated with prednisone, with azathioprine combination in 16.7% of the patients. At 6 months post initial treatment, twenty patients (66.7%) achieved biochemical remission, four patients had incomplete response, two patients failed to improve (one died during the induction of remission period due to AIH-related complications), and four patients were lost to follow-up. This study provided an updated overview of AIH in Jordan. The results showed typical female predominance, and interestingly high rates of acute presentation and seronegative disease. Future longitudinal studies are recommended to address the nature and long-term prognosis of AIH in Jordan. MDPI 2023-01-12 /pmc/articles/PMC9861091/ /pubmed/36675558 http://dx.doi.org/10.3390/jcm12020629 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Tamimi, Tarek A.
Sallam, Malik
Rayyan, Deema
Farah, Randa
Alkhulaifat, Dana
Al-Ani, Abdallah
Elmusa, Reem
Sharawi, Said
Tanash, Omar
Rayyan, Yaser
Clinical Characteristics of Autoimmune Hepatitis in a Middle Eastern Population: A Tertiary Care Center Experience
title Clinical Characteristics of Autoimmune Hepatitis in a Middle Eastern Population: A Tertiary Care Center Experience
title_full Clinical Characteristics of Autoimmune Hepatitis in a Middle Eastern Population: A Tertiary Care Center Experience
title_fullStr Clinical Characteristics of Autoimmune Hepatitis in a Middle Eastern Population: A Tertiary Care Center Experience
title_full_unstemmed Clinical Characteristics of Autoimmune Hepatitis in a Middle Eastern Population: A Tertiary Care Center Experience
title_short Clinical Characteristics of Autoimmune Hepatitis in a Middle Eastern Population: A Tertiary Care Center Experience
title_sort clinical characteristics of autoimmune hepatitis in a middle eastern population: a tertiary care center experience
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861091/
https://www.ncbi.nlm.nih.gov/pubmed/36675558
http://dx.doi.org/10.3390/jcm12020629
work_keys_str_mv AT tamimitareka clinicalcharacteristicsofautoimmunehepatitisinamiddleeasternpopulationatertiarycarecenterexperience
AT sallammalik clinicalcharacteristicsofautoimmunehepatitisinamiddleeasternpopulationatertiarycarecenterexperience
AT rayyandeema clinicalcharacteristicsofautoimmunehepatitisinamiddleeasternpopulationatertiarycarecenterexperience
AT farahranda clinicalcharacteristicsofautoimmunehepatitisinamiddleeasternpopulationatertiarycarecenterexperience
AT alkhulaifatdana clinicalcharacteristicsofautoimmunehepatitisinamiddleeasternpopulationatertiarycarecenterexperience
AT alaniabdallah clinicalcharacteristicsofautoimmunehepatitisinamiddleeasternpopulationatertiarycarecenterexperience
AT elmusareem clinicalcharacteristicsofautoimmunehepatitisinamiddleeasternpopulationatertiarycarecenterexperience
AT sharawisaid clinicalcharacteristicsofautoimmunehepatitisinamiddleeasternpopulationatertiarycarecenterexperience
AT tanashomar clinicalcharacteristicsofautoimmunehepatitisinamiddleeasternpopulationatertiarycarecenterexperience
AT rayyanyaser clinicalcharacteristicsofautoimmunehepatitisinamiddleeasternpopulationatertiarycarecenterexperience